Skip to main content
VCbacked
Log inGet Started

Prolific Machines

Emeryville, United States

Prolific Machines unlocks production of next-generation therapeutics with a light-controlled gene expression system and closed-loop control.

$55.0M raised
Jun 2024
Series B
BiotechnologyHealth CareLife ScienceMachine LearningManufacturing

Top Investors

Mayfield FundSOSVBreakthrough Energy VenturesIndieBioBreyer Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Prolific Machines

How much funding has Prolific Machines raised?
Prolific Machines has raised $55.0M in total funding. The most recent round was Series B. The last funding was announced in June 2024.
Who are Prolific Machines's investors?
Prolific Machines's investors include Mayfield Fund, SOSV, Breakthrough Energy Ventures, IndieBio, Breyer Capital.
Where is Prolific Machines headquartered?
Prolific Machines is headquartered in Emeryville, United States.
What does Prolific Machines do?
Prolific Machines unlocks production of next-generation therapeutics with a light-controlled gene expression system and closed-loop control.
What stage is Prolific Machines at?
Prolific Machines is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Prolific Machines — Funding & Investors." VCBacked, June 6, 2024, https://www.vcbacked.co/company/prolific-machines. Accessed June 4, 2026.
APA
VCBacked. (2024). Prolific Machines — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/prolific-machines
Wikipedia (cite web)
{{cite web |title=Prolific Machines — Funding & Investors |url=https://www.vcbacked.co/company/prolific-machines |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong